Cargando…

Illness Experience of Patients with Chronic Hepatitis C Participating in Clinical Trials

OBJECTIVES: To understand the illness experience of patients with chronic hepatitis C participating in clinical trials in the sociocultural context of Korea in an in-depth and comprehensive manner. METHODS: A focused ethnography approach was used to discover the pattern of illness experience of pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hoo-Jeung, Park, Euna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korea Centers for Disease Control and Prevention 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5194226/ https://www.ncbi.nlm.nih.gov/pubmed/28053846 http://dx.doi.org/10.1016/j.phrp.2016.11.001

Ejemplares similares

Quality of Life of Chronic Hepatitis C Patients and Its Associated Factors
por: Cho, Hoo Jeung, et al.
Publicado: (2017)

Development and Evaluation of an Antiviral Agent Medication Adherence Education Program for Patients with Chronic Hepatitis C
por: Cho, Hoo Jeung, et al.
Publicado: (2020)

Canonical Correlation Between Self-Care Agency and Health-Related Self-Efficacy with Chronic Viral Hepatitis Patients
por: Cho, HooJeung, et al.
Publicado: (2019)

The role of illness perceptions in labor participation of the chronically ill
por: Boot, Cécile R. L., et al.
Publicado: (2008)

“The invisible”: Participant's experiences in clinical trials
por: Nadimpally, Sarojini, et al.
Publicado: (2017)

Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients
por: Jang, Jae Young, et al.
Publicado: (2011)

Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
por: Cho, Yuri, et al.
Publicado: (2015)

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
por: Cho, Eun Ju, et al.
Publicado: (2012)

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C
por: Reddy, K Rajender, et al.
Publicado: (2012)

Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
por: Jeong, Seok Hoo, et al.
Publicado: (2012)

Relationship of hepatitis C risk to hepatitis C test acceptance among adult patients participating in an ED hepatitis C screening programme
por: Cowan, Ethan, et al.
Publicado: (2023)

Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience
por: Lake, Jordan E, et al.
Publicado: (2011)

The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial
por: Lally, John, et al.
Publicado: (2018)

Patients' experiences of the decision‐making process for clinical trial participation
por: A. Gregersen, Trine, et al.
Publicado: (2022)

Issues contributing to non-attendance for chronic illness care for hepatitis C
por: Butt, Gail, et al.
Publicado: (2012)

Informed consent in critically ill adults participating to a randomized trial
por: Guinchard, Milène, et al.
Publicado: (2020)

Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
por: Kim, Hong Joo, et al.
Publicado: (2017)

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
por: Kim, Yu Jin, et al.
Publicado: (2011)

Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C
por: Kim, Mi Na, et al.
Publicado: (2016)

Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
por: Park, Soo-Jeung, et al.
Publicado: (2023)

Experience of Late–Middle-Aged Women who Reside in Small and Medium-Sized Cities in Becoming Psychologically Mature Women
por: Park, Euna, et al.
Publicado: (2015)

Dose‐response Trial of Lactoferrin in Patients with Chronic Hepatitis C
por: Okada, Shuichi, et al.
Publicado: (2002)

The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices
por: Peterson, Ilse S., et al.
Publicado: (2022)

Evaluated outcomes in patients with Chronic Hepatitis C
por: Ashtari, Sara, et al.
Publicado: (2013)

Seroprevalence of Hepatitis A in Patients with Chronic Hepatitis C in Isfahan Province
por: Shoaei, Parisa, et al.
Publicado: (2012)

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
por: Stan, Ionelia Sorina, et al.
Publicado: (2021)

The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection
por: Kang, Jin Gu, et al.
Publicado: (2023)

Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection
por: George, Jacob, et al.
Publicado: (2018)

Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
por: Ahn, Young-Hwan, et al.
Publicado: (2019)

The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
por: Han, Sung Yong, et al.
Publicado: (2021)

Participants’ uptake of clinical trial results: a randomised experiment
por: Mancini, J, et al.
Publicado: (2010)

Online Activity and Participation in Treatment Affects the Perceived Efficacy of Social Health Networks Among Patients With Chronic Illness
por: Magnezi, Racheli, et al.
Publicado: (2014)

Patient and Caregiver Experiences of Participating in Parkinson’s Disease Clinical Trials: A Systematic Review of Qualitative Studies
por: Gorzynska, Olivia, et al.
Publicado: (2021)

Effect of Pharmacist-Led Intervention in Elderly Patients through a Comprehensive Medication Reconciliation: A Randomized Clinical Trial
por: Lee, Sunmin, et al.
Publicado: (2023)

Experience with direct-acting antivirals in genotype 1–5 infected chronic hepatitis C patients in Turkey
por: Sahin, Ahmet, et al.
Publicado: (2023)

Elderly patients’ participation in clinical trials
por: Shenoy, Premnath, et al.
Publicado: (2015)

Motivations, barriers and experiences of participants in an HIV reservoir trial
por: De Scheerder, Marie-Angélique, et al.
Publicado: (2021)

Chronic Hepatitis C: Pathophysiology and Clinical Issues
por: Abate, Maria Lorena, et al.
Publicado: (2022)

Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C
por: Poortahmasebi, Vahdat, et al.
Publicado: (2016)

Communicating the Experience of Chronic Pain and Illness Through Blogging
por: Ressler, Pamela Katz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1f701ktqpje3pl7nk123oe3ms0